1 – 10 of 32
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Curative treatment for oligometastatic gastroesophageal cancer– results of a prospective multicenter study
(
- Contribution to journal › Article
-
Mark
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell Carcinoma
(
- Contribution to journal › Article
-
Mark
Prediction of survival after pancreatoduodenectomy for distal cholangiocarcinoma : independent external validation of a prognostic model for 3-year overall survival in Sweden
2025) In Scandinavian Journal of Gastroenterology(
- Contribution to journal › Article
- 2024
-
Mark
Predictive Models for Assessing Patients’ Response to Treatment in Metastatic Prostate Cancer : A Systematic Review
(
- Contribution to journal › Scientific review
-
Mark
Cytarabine dose intensification improves survival in older patients with secondary/high-risk acute myeloid leukemia in matched real-world versus clinical trial data
(
- Contribution to journal › Article
-
Mark
Preoperatively suspected gallbladder cancer improves survival compared with incidental gallbladder cancer in pT3 patients
(
- Contribution to journal › Article
-
Mark
Real-World Treatment Patterns and Survival Outcomes for Patients with Non-Metastatic Non-Small-Cell Lung Cancer in Sweden : A Nationwide Registry Analysis from the I-O Optimise Initiative
(
- Contribution to journal › Article
- 2023
-
Mark
Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?
(
- Contribution to journal › Article
-
Mark
A trans-omics assessment of gene–gene interaction in early-stage NSCLC
(
- Contribution to journal › Article
-
Mark
Surgical outcomes of gallbladder cancer: the OMEGA retrospective, multicentre, international cohort study
(
- Contribution to journal › Article